Tao DL - Search Results

1

Ibrutinib-associated bleeding: pathogenesis, management and risk reduction strategies.

Shatzel JJ, Olson SR, Tao DL, McCarty OJT, Danilov AV, DeLoughery TG. Shatzel JJ, et al. Among authors: tao dl. J Thromb Haemost. 2017 May;15(5):835-847. doi: 10.1111/jth.13651. Epub 2017 Mar 27. J Thromb Haemost. 2017. PMID: 28182323 Free PMC article. Review.

2

Extended thromboprophylaxis with direct oral anticoagulants for medical patients: a systematic review and meta-analysis.

Tao DL, Bien JY, DeLoughery TG, Shatzel JJ. Tao DL, et al. Blood. 2017 Feb 2;129(5):653-655. doi: 10.1182/blood-2016-10-747931. Epub 2016 Dec 20. Blood. 2017. PMID: 27998890 Free article. Review. No abstract available.

3

More efficacious, equally safe: a meta-analysis comparing the safety of direct oral anticoagulants versus aspirin.

Bien JY, Tao DL, Daughety MM, DeLoughery TG, Shatzel JJ. Bien JY, et al. Among authors: tao dl. J Thromb Thrombolysis. 2018 Jul;46(1):22-23. doi: 10.1007/s11239-018-1648-8. J Thromb Thrombolysis. 2018. PMID: 29569119 Review. No abstract available.

4

Evaluating the Effects of an Evidence-Based Hemostasis and Thrombosis Treatment Algorithm on Medical Practitioner and Trainee Clinical Decision-Making.

Olson SR, Shatzel JJ, Tao D, Wasp G, DeLoughery TG. Olson SR, et al. Semin Thromb Hemost. 2018 Jun;44(4):400-403. doi: 10.1055/s-0038-1642642. Epub 2018 May 3. Semin Thromb Hemost. 2018. PMID: 29723891 No abstract available.

5

The efficacy and safety of DOACs versus LMWH for cancer-associated thrombosis: A systematic review and meta-analysis.

Tao DL, Olson SR, DeLoughery TG, Shatzel JJ. Tao DL, et al. Eur J Haematol. 2020 Sep;105(3):360-362. doi: 10.1111/ejh.13453. Epub 2020 Jun 18. Eur J Haematol. 2020. PMID: 32441350 Free PMC article. No abstract available.

6

Aspirin and antiplatelet treatments in cancer.

Tao DL, Tassi Yunga S, Williams CD, McCarty OJT. Tao DL, et al. Blood. 2021 Jun 10;137(23):3201-3211. doi: 10.1182/blood.2019003977. Blood. 2021. PMID: 33940597 Free PMC article.

7

Assessing the risk of thromboembolism in cancer patients receiving immunotherapy.

Goel A, Khorana A, Kartika T, Gowda S, Tao DL, Thawani R, Shatzel JJ. Goel A, et al. Among authors: tao dl. Eur J Haematol. 2022 Apr;108(4):271-277. doi: 10.1111/ejh.13734. Epub 2022 Jan 13. Eur J Haematol. 2022. PMID: 34905252 Free PMC article. Review.

8

Association of PD-L1 expression, tumor mutational burden and immunotherapy with venous thrombosis in patients with solid organ malignancies.

Thawani R, Kartika T, Elstrott B, Batiuk E, Tao D, Gowda S, Chen L, Lavasseur C, Tun N, Taflin NF, Shatzel J. Thawani R, et al. Thromb Res. 2022 Sep;217:12-14. doi: 10.1016/j.thromres.2022.06.012. Epub 2022 Jun 30. Thromb Res. 2022. PMID: 35816991 Free PMC article. No abstract available.

9

Screening for occult cancer after unprovoked venous thromboembolism: Assessing the current literature and future directions.

Patel SS, Tao D, McMurry HS, Shatzel JJ. Patel SS, et al. Eur J Haematol. 2023 Jan;110(1):24-31. doi: 10.1111/ejh.13874. Epub 2022 Oct 17. Eur J Haematol. 2023. PMID: 36192850 Free PMC article. Review.

10

Choice of control group in randomised trials of cancer medicine: are we testing trivialities?

Tao D, Prasad V. Tao D, et al. Lancet Oncol. 2018 Sep;19(9):1150-1152. doi: 10.1016/S1470-2045(18)30501-1. Lancet Oncol. 2018. PMID: 30191836 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters